[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Universal Biosensors Inc (UBI.AX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in thousands)

	12-2014	12-2013	12-2012	12-2011	12-2010
Cash Flows From Operating Activities
Depreciation Amortization	2,513	2,497	2,637	N/A	N/A
Accounts receivable	-1,632	404	2,607	N/A	N/A
Other Working Capital	1,101	-8,208	2,253	N/A	N/A
Other Operating Activity	-7,396	-11,322	-10,797	0	0
Operating Cash Flow	$-5,414	$-16,629	$-3,301	$N/A	$N/A

Cash Flows From Investing Activities
PPE Investments	-947	-159	-687	-1,103	-2,320
Investing Cash Flow	$-947	$-159	$-687	$-1,103	$-2,320

Cash Flows From Financing Activities
Change In Short Term Borrowing	499	16,909	N/A	N/A	N/A
Debt Issued	N/A	N/A	922	N/A	N/A
Debt Repayment	N/A	N/A	-922	N/A	N/A
Common Stock Issued	0	0	13,164	80	715
Other Financing Activity	-2,291	-569	-616	0	0
Financing Cash Flow	$-1,792	$16,340	$12,548	$80	$715

Exchange Rate Effect	741	541	N/A	N/A	N/A
Beginning Cash Position	23,742	23,649	15,089	23,272	31,291
End Cash Position	16,330	23,742	23,649	15,089	23,272
Net Cash Flow	$-8,154	$-448	$8,560	$-8,183	$-8,019

Free Cash Flow
Operating Cash Flow	-5,414	-16,629	-3,301	N/A	N/A
Capital Expenditure	-955	-159	-687	-1,103	-2,320
Free Cash Flow	-6,369	-16,788	-3,988	-1,103	-2,320